DRTSW — Alpha Tau Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1871321 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -13,782,000 | -45,813,000 | 134,250,000 | 22,993,000 | 90,195,000 |
| Mar 2026 | 0 | — | -13,313,000 | -22,939,000 | 108,773,000 | 4,636,000 | 39,421,000 |
| Dec 2025 | 0 | — | -12,602,000 | -12,136,000 | 105,652,000 | 12,202,000 | 28,553,000 |
| Sep 2025 | 0 | — | -10,730,000 | -11,686,000 | 104,694,000 | 3,329,000 | 27,110,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-213,075,000
Inventory
—
Receivables
$1,121,000
ST Investments
$71,783,000
EBIT TTM
$-46,164,000
Pretax Income TTM
$-56,864,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -42,288,000 | -42,627,000 | 105,652,000 | 28,553,000 | 77,099,000 | -26,681,000 |
| Dec 2024 | 0 | -36,042,000 | -31,750,000 | 86,204,000 | 23,538,000 | 62,666,000 | -19,783,000 |
| Dec 2023 | 0 | -35,680,000 | -29,157,000 | 107,388,000 | 22,913,000 | 84,475,000 | -17,958,000 |
| Dec 2022 | 0 | -32,136,000 | -33,762,000 | 120,149,000 | 14,492,000 | 105,657,000 | -23,879,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $145.17B | $405.18 | — |
| MDT | Medtronic plc | $113.38B | $88.64 | — |
| SYK | STRYKER CORP | $104.47B | $272.36 | — |
| MMM | 3M CO | $87.44B | $169.55 | — |
| BSX | BOSTON SCIENTIFIC CORP | $63.65B | $43.92 | — |
News headlines (Yahoo Finance, 1h cache)
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
2026-07-15 12:30 · Yahoo
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
2026-06-11 12:30 · Yahoo
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-18 20:01 · Yahoo
Alpha Tau to Participate in September Investor Conferences
2026-09-02 12:00 · Yahoo
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
2026-08-31 12:00 · Yahoo
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
2026-08-28 09:30 · Yahoo
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
2026-08-17 12:00 · Yahoo
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
2026-08-10 20:01 · Yahoo
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
2026-08-01 06:16 · Yahoo
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic H
2026-07-21 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.